Completed
Additive Value of Biomarkers on SCD Risk
Class Central Classrooms beta
YouTube videos curated by Class Central.
Classroom Contents
Predicting and Preventing Sudden Cardiac Death in Patients Without Systolic Dysfunction
Automatically move to the next video in the Classroom when playback concludes
- 1 Intro
- 2 Sudden Cardiac Death and Out-of-Hospital Cardiac Arrest
- 3 Racial and Sex Differences in Sudden Cardiac Death: The REGARDS Study
- 4 Lifetime Cumulative Incidence of SCD in ARIC by Race and Sex groups
- 5 Causes of Sudden Cardiac Death
- 6 Prospective Autopsy Characterization of Sudden Cardiac Death in San Francisco County: POST SCD Study
- 7 Mechanism of Sudden Cardiac Death
- 8 Proportion of EMS treated Cardiac Arrests with VF as Initial Rhythm in Seattle, USA
- 9 Treatment: Cardiopulmonary Resuscitation and Defibrillation
- 10 First Documented Cardiac Rhythm in Witnessed Arrests/ROC Epistry-Cardiac Arrest
- 11 Future Approaches to Resuscitation
- 12 Current Approach to SCD Prevention
- 13 Primary Prevention of SCD: ICD Trials
- 14 Wearable Defibrillator after Acute MI: The VEST Trial
- 15 LV Dysfunction and ICD Utilization after MI:Pre-SCD II Registry
- 16 Paradigm HF
- 17 LVEF and SCD Implications for Prevention and ICD Utilization
- 18 Estimating Myocardial Infarction Size With a Simple Electrocardiographic Marker Score
- 19 Arrhythmic Sudden Death Survival Prediction using Deep Learning Analysis of MRI SCAR in CHD
- 20 Biomarkers and SCD in the General Population
- 21 Replication of Biomarkers in the Population: Harvard SCD Consortium
- 22 Additive Value of Biomarkers on SCD Risk
- 23 Familial Aggregation of SCD
- 24 GWAS of Sudden Cardiac Arrest in General Population
- 25 Genetic Risk Scores and Sudden Cardiac Arrest: Mendelian Randomization
- 26 Rare Sequence Variation and SCD Exome Sequencing
- 27 Characteristics of SCD cases and controls
- 28 Filtration and Classification of Variants identified by Exome Sequencing
- 29 Pathogenic or Likely Pathogenic Variants in MESA Population
- 30 ECG Measures and SCD Risk General Population Studies
- 31 Absolute Incidence of SCD across High and Low Risk Populations
- 32 SCD Prevention in General Populations: Healthy Lifestyle and SCD
- 33 Sudden Death in HFPEF - TOPCAT Trial
- 34 PRE-DETERMINE Cohort Study (R01HL091069)SCD Risk Prediction in Patients without Severe Systolic Dysfunction
- 35 PREDETERMINE Baseline Characteristics
- 36 LVEF and Mode of Death in PRE-DETERMINE
- 37 Differential Association of Clinical Risk Factors With Sudden and/or Arrhythmic Death (SAD) vs. Competing Modes of Death
- 38 Age and Risk of Sudden and/or Arrhythmic Death (SAD) vs. Competing Modes of Death
- 39 Potential Impact of Absolute Risk on ICD Benefit: Number Needed to Treat (NNT) to Save One Life
- 40 Competing Risks and ICD Benefit: Proportional SAD Risk and Percent Mortality Reduction
- 41 DANISH TRIAL: IMPACT OF AGE ON COMPETING RISK
- 42 Importance of Competing Risk in Selecting Candidates for ICD Therapy
- 43 The ECG Stratifies SCD in Coronary Heart Disease Patients PREDETERMINE and ARTEMIS
- 44 Polygenic Risk Score (PRS) for CAD Specifically Predicts SAD in PREDETERMINE
- 45 Polygenic Risk Score (PRS): Additive SAD Risk Prediction to Clinical Factors and ECG
- 46 Summary: Challenges to Reducing Mortality from Sudden Cardiac Death
- 47 The Next Frontier: Moving Beyond the Low LVEF Population
